National Health Investors, Inc. Common Stock (NHI)
Financial Services › Real Estate Investment Trusts
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- Trading 67% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 9.5% — below-average profitability
- Revenue growing at 12% annually
National Health Investors, Inc. Common Stock (NHI) is a Financial Services company operating in Real Estate Investment Trusts, listed on the NYSE , with a market capitalisation of $3.7 billion . Key value metrics: P/E ratio 25.7, P/B ratio 2.45, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
National Health Investors, Inc. Common Stock — Fundamental Analysis Summary
National Health Investors, Inc. Common Stock (NHI) is currently trading 67% above its Graham Number of $45.72, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.7x.
On financial health, NHI shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 9.5% (sector average: 4.9%), and manageable leverage with a debt-to-equity ratio of 0.83.
StockPik's composite Value Score for NHI is 55/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NHI shows revenue growing at 12% year-over-year, with earnings growing at 3%.
NHI pays a solid dividend yield of 4.8%.